Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2001 3
2002 3
2003 3
2004 4
2005 5
2006 6
2007 1
2008 5
2009 6
2010 6
2011 5
2012 6
2013 9
2014 10
2015 11
2016 12
2017 4
2018 6
2019 10
2020 11
2021 19
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Iriguchi S, Yasui Y, Kawai Y, Arima S, Kunitomo M, Sato T, Ueda T, Minagawa A, Mishima Y, Yanagawa N, Baba Y, Miyake Y, Nakayama K, Takiguchi M, Shinohara T, Nakatsura T, Yasukawa M, Kassai Y, Hayashi A, Kaneko S. Iriguchi S, et al. Among authors: nakatsura t. Nat Commun. 2021 Jan 18;12(1):430. doi: 10.1038/s41467-020-20658-3. Nat Commun. 2021. PMID: 33462228 Free PMC article.
Next-Generation Cancer Immunotherapy Targeting Glypican-3.
Shimizu Y, Suzuki T, Yoshikawa T, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: nakatsura t. Front Oncol. 2019 Apr 10;9:248. doi: 10.3389/fonc.2019.00248. eCollection 2019. Front Oncol. 2019. PMID: 31024850 Free PMC article. Review.
Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Tsuchiya N, et al. Among authors: nakatsura t. World J Gastroenterol. 2015 Oct 7;21(37):10573-83. doi: 10.3748/wjg.v21.i37.10573. World J Gastroenterol. 2015. PMID: 26457017 Free PMC article. Review.
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, Takiguchi M, Kassai Y, Imai E, Yasui Y, Kawai Y, Zhang R, Uemura Y, Miyoshi H, Nakanishi M, Watanabe A, Hayashi A, Kawana K, Fujii T, Nakatsura T, Kaneko S. Minagawa A, et al. Among authors: nakatsura t. Cell Stem Cell. 2018 Dec 6;23(6):850-858.e4. doi: 10.1016/j.stem.2018.10.005. Epub 2018 Nov 15. Cell Stem Cell. 2018. PMID: 30449714 Free article.
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T, Kumagai A, Iriguchi S, Yasui Y, Miyasaka T, Nakagoshi K, Nakane K, Saito K, Takahashi M, Sasaki A, Yoshida S, Takasu N, Seno H, Uemura Y, Tamada K, Nakatsura T, Kaneko S. Ueda T, et al. Among authors: nakatsura t. Cancer Sci. 2020 May;111(5):1478-1490. doi: 10.1111/cas.14374. Epub 2020 Mar 31. Cancer Sci. 2020. PMID: 32133731 Free PMC article.
Cancer immunotherapy-targeted glypican-3 or neoantigens.
Shimizu Y, Suzuki T, Yoshikawa T, Tsuchiya N, Sawada Y, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: nakatsura t. Cancer Sci. 2018 Mar;109(3):531-541. doi: 10.1111/cas.13485. Epub 2018 Feb 14. Cancer Sci. 2018. PMID: 29285841 Free PMC article. Review.
[Era of cancer immunotherapy has come].
Nakatsura T. Nakatsura T. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):164-71. doi: 10.2177/jsci.39.164. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27320931 Free article. Review. Japanese.
129 results